Iowa House Bill HF2192

Iowa 2023-2024 Regular Session

• Introduced: 1/29/24
• Refer: 1/29/24

Caption

A bill for an act providing a standing appropriation for pediatric cancer research at the university of Iowa hospitals and clinics.

Impact

This legislation represents a significant commitment to pediatric cancer research, establishing a financial mechanism that ties funding to the state's population. This approach may provide a stable stream of resources that can adjust with demographic changes, potentially enhancing research efforts targeted at improving outcomes for children affected by cancer. Furthermore, the bill mandates that the state board of regents report on the expenditures annually to the governor and the general assembly, promoting accountability and transparency in the use of these funds.

Summary

House File 2192 proposes a standing appropriation for pediatric cancer research at the University of Iowa Hospitals and Clinics. The bill specifies that for the fiscal year beginning July 1, 2024, and for each subsequent fiscal year, a dollar amount equal to the population of Iowa on July 1 of that year will be appropriated from the state's general fund to support this research. This aims to ensure continuous funding for pediatric cancer initiatives at a prominent state medical institution.

Contention

While the bill appears to have positive implications for healthcare funding, there may be points of contention related to its potential impact on the overall state budget. Critics could argue that tying appropriations to population estimates may lead to fluctuations in available funding over time, which could complicate planning for long-term research projects. Additionally, stakeholders might raise concerns regarding the prioritization of funding for pediatric cancer research over other areas of healthcare or education that also require support.

Additional_points

Support for HF2192 is likely to be broad, given the public health benefits associated with enhancing pediatric cancer research. However, it will be essential to monitor how the allocation of funds aligns with other healthcare funding needs within the state, ensuring a balanced approach to addressing the diverse health challenges faced by Iowa's residents.